224 related articles for article (PubMed ID: 32191918)
41. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
Zarà M; Canobbio I; Visconte C; Canino J; Torti M; Guidetti GF
Cell Signal; 2018 Aug; 48():45-53. PubMed ID: 29705335
[TBL] [Abstract][Full Text] [Related]
43. Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy.
Patel D; Väänänen H; Jirousková M; Hoffmann T; Bodian C; Coller BS
Blood; 2003 Feb; 101(3):929-36. PubMed ID: 12529292
[TBL] [Abstract][Full Text] [Related]
44. [Vascular endothelial growth factor secreted by breast cancer cells plays a critical role in the formation of pre-metastatic niche in the mouse lung].
Li R; Yuan B; Zhang Y; Dai J; Zhang P; Fang F; Han M
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):17-22. PubMed ID: 26796801
[TBL] [Abstract][Full Text] [Related]
45. Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.
Johnson KE; Forward JA; Tippy MD; Ceglowski JR; El-Husayni S; Kulenthirarajan R; Machlus KR; Mayer EL; Italiano JE; Battinelli EM
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):664-674. PubMed ID: 28153880
[TBL] [Abstract][Full Text] [Related]
46. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
47. Alterations in NO- and PGI
Buczek E; Denslow A; Mateuszuk L; Proniewski B; Wojcik T; Sitek B; Fedorowicz A; Jasztal A; Kus E; Chmura-Skirlinska A; Gurbiel R; Wietrzyk J; Chlopicki S
BMC Cancer; 2018 May; 18(1):582. PubMed ID: 29788918
[TBL] [Abstract][Full Text] [Related]
48. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
Li S; Xu X; Jiang M; Bi Y; Xu J; Han M
Mol Med Rep; 2015 Jun; 11(6):4454-62. PubMed ID: 25625500
[TBL] [Abstract][Full Text] [Related]
49. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
50. Establishment of a novel orthotopic model of breast cancer metastasis to the lung.
Guo W; Zhang S; Liu S
Oncol Rep; 2015 Jun; 33(6):2992-8. PubMed ID: 25963127
[TBL] [Abstract][Full Text] [Related]
51. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
Gebremeskel S; LeVatte T; Liwski RS; Johnston B; Bezuhly M
Int J Cancer; 2015 Jan; 136(1):234-40. PubMed ID: 24798403
[TBL] [Abstract][Full Text] [Related]
52. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.
Uppal A; Wightman SC; Ganai S; Weichselbaum RR; An G
Theor Biol Med Model; 2014 Apr; 11():17. PubMed ID: 24725600
[TBL] [Abstract][Full Text] [Related]
54. Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism.
Raja S; Avraham S; Avraham H
J Biol Chem; 1997 Apr; 272(16):10941-7. PubMed ID: 9099753
[TBL] [Abstract][Full Text] [Related]
55. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
56. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production.
Peck-Radosavljevic M; Wichlas M; Zacherl J; Stiegler G; Stohlawetz P; Fuchsjäger M; Kreil A; Metz-Schimmerl S; Panzer S; Steininger R; Mühlbacher F; Ferenci P; Pidlich J; Gangl A
Blood; 2000 Feb; 95(3):795-801. PubMed ID: 10648388
[TBL] [Abstract][Full Text] [Related]
57. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.
Amirkhosravi A; Amaya M; Siddiqui F; Biggerstaff JP; Meyer TV; Francis JL
Platelets; 1999; 10(5):285-92. PubMed ID: 16801104
[TBL] [Abstract][Full Text] [Related]
58. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity--a comparison with Scott syndrome.
Weiss HJ; Lages B
Blood; 1997 Mar; 89(5):1599-611. PubMed ID: 9057642
[TBL] [Abstract][Full Text] [Related]
59. Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.
Alexander ET; Minton AR; Hayes CS; Goss A; Van Ryn J; Gilmour SK
Cancer Biol Ther; 2015; 16(12):1802-11. PubMed ID: 26383051
[TBL] [Abstract][Full Text] [Related]
60. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
Parker RI; Gralnick HR
Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
